Healthcare -
Biotechnology - NASDAQ - US
$ 13.49
-0.369 %
$ 195 M
Market Cap
0.11
P/E
INBX - OTHER LONG-TERM ASSETS
Other Long-term Assets INBX - Inhibrx Biosciences, Inc.
3.16 M
LAST VALUE
30.88%
2 YEAR CAGR
12.78%
5 YEAR CAGR
0.00%
10 YEAR CAGR